Publicaciones (94) Publicaciones de FELIPE COUÑAGO LORENZO

2024

  1. A randomised trial of short- vs long-term androgen deprivation with salvage radiotherapy for biochemical failure following radical prostatectomy: URONCOR 06-24

    BJU International, Vol. 134, Núm. 4, pp. 568-577

  2. Analyzing diagnostic and treatment wait times for lung cancer Patients: Key insights from a provincial registry study

    Lung Cancer, Vol. 194

  3. Correction to: MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention (Magnetic Resonance Materials in Physics, Biology and Medicine, (2024), 37, 3, (323-328), 10.1007/s10334-024-01176-5)

    Magnetic Resonance Materials in Physics, Biology and Medicine

  4. Docetaxel Provides Oncological Benefits in the Era of New-Generation Androgen Receptor Inhibitors - or Is Three a Crowd?

    Clinical Genitourinary Cancer, Vol. 22, Núm. 1, pp. 56-66

  5. Feasibility and Acute Toxicity of Hypo-Fractionated Radiotherapy on 0.35T MR-LINAC: The First Prospective Study in Spain

    Cancers, Vol. 16, Núm. 9

  6. Hypofractionated whole breast IMRT with HDR brachytherapy boost in early-stage breast cancer: Long-term results from a single-center

    Brachytherapy, Vol. 23, Núm. 3, pp. 342-354

  7. Interstitial Lung Disease Caused by Apalutamide for Metastatic Castration-Sensitive Prostate Cancer

    Archivos de Bronconeumologia, Vol. 60, Núm. 8, pp. 537-538

  8. Is There an Opportunity to De-Escalate Treatments in Selected Patients with Metastatic Hormone-Sensitive Prostate Cancer?

    Cancers, Vol. 16, Núm. 13

  9. Is trimodal therapy the current standard for muscle-invasive bladder cancer?

    Actas Urologicas Espanolas, Vol. 48, Núm. 5, pp. 345-355

  10. MR beyond diagnostics at the ESMRMB annual meeting: MR theranostics and intervention

    Magnetic Resonance Materials in Physics, Biology and Medicine

  11. MR-LINAC, a New Partner in Radiation Oncology: Current Landscape

    Cancers, Vol. 16, Núm. 2

  12. Multidisciplinary approach for locally advanced non-small cell lung cancer (NSCLC): 2023 expert consensus of the Spanish lung cancer group GECP. Controversies and discussion

    Clinical and Translational Oncology

  13. PEACE V-Salvage Treatment of OligoRecurrent nodal prostate cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial

    European urology oncology, Vol. 7, Núm. 3, pp. 462-468

  14. Prospective study of HDR brachytherapy (BT), external beam radiotherapy (EBRT) and androgen deprivation therapy (ADT): 10-years experience of an MRI-guided approach

    Radiotherapy and Oncology, Vol. 190

  15. Real-Life Impact of Hypofractionated IMRT in Early Breast Cancer on Cardiovascular Risk

    International Journal of Radiation Oncology*Biology*Physics

  16. Recommendations on the Treatment of Metastatic Hormone-Sensitive Prostate Cancer: Patient Selection

    Actas Urologicas Espanolas, Vol. 48, Núm. 9, pp. 623-631

  17. Stereotactic body radiation therapy (SBRT): a new treatment option in renal cancer

    Actas Urologicas Espanolas

  18. Total Neoadjuvant Therapy Approach for the Treatment of Locally Advanced Rectal Cancer: Where Do We Stand?

    Oncology (Switzerland), Vol. 102, Núm. 7, pp. 646-657

2023

  1. Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis

    Clinical Oncology, Vol. 35, Núm. 12, pp. e676-e688

  2. Coronavirus disease 2019 and lung cancer: where are we?

    Exploration of Targeted Anti-tumor Therapy, Vol. 4, Núm. 5, pp. 1082-1094